Align Technology (ALGN) shares rallied 14.4% in the last trading session to close at $165.03. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.6% loss over the past four weeks.Align Technology scored a strong price increase on investors’ optimism surrounding its impending 2025 first-quarter financial results, slated to release on Apr. 30 after the market closes. In the last reported fourth quarter, the bott ...

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings esti ...

Align Technology, Inc. (ALGN) recently made its Invisalign System with mandibular advancement featuring occlusal blocks commercially available. It is designed for Class II skeletal and dental correction with simultaneous teeth alignment.The latest clinical innovation is expected to expand Align Technology’s Class II treatment portfolio for kids and teenage patients, offering practitioners a comprehensive solution. ALGN Stock’s Likely Trend Following the NewsAfter the announcement, shares of ALGN increased 3 ...

Core Insights - Align Technology is strategically positioning itself to capture the growing malocclusion market, which has a significant portion of untreated individuals, through various strategic alliances and geographic expansion [1][3][10] Company Performance - Align Technology's stock has decreased by 49.1% over the past year, contrasting with a 3.1% decline in the industry and a 7.7% increase in the S&P 500 [2] - The company has a market capitalization of $11.66 billion and projects a long-term estimated earnings growth rate of 10.6%, higher than the industry's 9.4% [2] - Align Technology has consistently surpassed earnings estimates in the past four quarters, with an average surprise of 3.5% [2] Market Opportunities - Malocclusion affects approximately 60% to 75% of the global population, equating to around 600 million people, presenting a substantial growth opportunity for Align Technology, particularly with its Invisalign Clear Aligner [3] - The company aims to increase its market share in orthodontic case starts, especially among teens and adults, by addressing negative perceptions of traditional braces and improving accessibility [3] Sales and Marketing Strategies - Align Technology has established strong relationships with dental support organizations (DSOs) and is focusing on marketing to young adults and teens through partnerships with athletes and influencers [5][6] - The company has expanded its marketing efforts in the EMEA region through social media platforms and testimonial campaigns [6] Geographic Expansion - By the end of 2023, Align Technology sold its products in over 100 countries and opened a new clear aligner fabrication facility in Wroclaw, Poland, enhancing its manufacturing capabilities [7][9] - The company reported strong growth in Clear Aligner sales in APAC, particularly in China and Japan, as well as in EMEA and Latin America [10] Challenges - Align Technology faces macroeconomic challenges, including staffing shortages, supply chain issues, and inflationary pressures, which are impacting revenues and margins [11] - The company's heavy reliance on the Invisalign Technology System for revenue raises concerns about its future success if market preferences shift towards competitors [12] Financial Estimates - The Zacks Consensus Estimate for Align Technology's 2025 earnings per share (EPS) is $9.99, with projected revenues of $4.09 billion, indicating a 2.3% increase from the previous year [13]

Group 1 - The Motley Fool is a financial services company founded in 1993, aiming to make the world smarter, happier, and richer [1] - The company reaches millions of people monthly through various channels including premium investing solutions, free guidance, market analysis on Fool.com, top-rated podcasts, and its non-profit foundation [1]

A month has gone by since the last earnings report for Align Technology (ALGN) . Shares have lost about 21.2% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Align Technology due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. ALGN Q4 Earnings Top Estimates, Revenue ...

Core Viewpoint - Align Technology (NASDAQ: ALGN) is currently undervalued, with a scenario presented where the business does not grow over the next five years and experiences a decrease in Adjusted EBIT Margins by 50 basis points, yet still arrives at the current share price [1] Company Analysis - The analysis suggests that Align Technology possesses durable competitive advantages and holds a significant moat over its industry, making it an attractive investment opportunity [1] - A discounted cash flow (DCF) approach is utilized for valuation, using historical data as a benchmark to generate forecasts [1]

Company Developments - Align Technology, Inc. has announced the addition of restorative capabilities to its next-generation iTero Lumina intraoral scanner and the new iTero Lumina Pro dental imaging system [1][2] - The enhancements aim to improve restorative workflows and support diagnostics of interproximal caries, thereby increasing practice efficiency for general practitioner dentists [2] - Current iTero Lumina scanner owners will receive new software updates with restorative and diagnostic support starting in April, following regulatory clearance [7] Market Performance - Following the announcement, Align Technology's shares increased by 0.6% to $173 [3] - The company currently has a market capitalization of $12.66 billion, with projected earnings growth of 6.6% in 2025 driven by a 2.3% increase in revenues [4] - In the past month, Align Technology's shares have declined by 44.6%, contrasting with a 3% decline in the industry [10] Industry Prospects - The global intraoral scanners market was valued at $969.4 million in 2023 and is expected to reach $2,816.4 million by 2035, growing at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2035 [8] - Market growth is attributed to advancements in digital dentistry, increased awareness of oral health, and greater adoption in orthodontics, prosthodontics, and restorative dentistry [8] Product Features - The iTero Lumina solutions offer up to five capabilities in one device, designed to reduce maintenance time and costs while automating daily tasks [5] - These solutions provide predictable and repeatable restoration fits, enhancing patient experience with quick and comfortable scanning [6]

Market Opportunity and Product Adoption - Clear Aligner net revenues accounted for approximately 81% of worldwide net revenues for the year ended December 31, 2024[14]. - Over 19 million people worldwide have been treated with the Invisalign System, indicating strong market penetration[15]. - Approximately 600 million people globally suffer from malocclusion, with only about 22 million seeking orthodontic treatment annually, representing a significant market opportunity[20]. - The share of orthodontic case starts treated with the Invisalign System is approximately 10% globally, highlighting potential for growth[20]. - The company focuses on increasing the utilization of existing doctors and educating consumers about the benefits of the Invisalign System to drive adoption[20]. - The Invisalign System offers various treatment packages tailored to different levels of malocclusion severity, enhancing its market appeal[25]. - The company aims to create awareness for Invisalign treatment among the potential 600 million patients who can benefit from treatment of malocclusion[11]. - The company is focused on increasing adoption of the Invisalign System and Vivera retainers by orthodontists and general practitioners worldwide[60]. Product Innovations and Technology - In 2024, several new products and technologies were launched, including the iTero Lumina intraoral scanner and Invisalign Outcome Simulator with Multiple Treatment Simulation[18]. - Approximately 94% of prescription orders for the Invisalign System are now submitted via digital scan, improving accuracy and efficiency[21]. - The Align Digital Platform aims to enhance treatment personalization and predictability through ongoing technological innovations[18]. - The Align Digital Workflow integrates software, systems, and services to streamline the treatment process from diagnosis to retention[22]. - The company continues to innovate its Invisalign treatment software, ClinCheck Pro, to enhance user experience and treatment control[50]. - The company received 510(k) clearance for the Invisalign Palatal Expander System in December 2023, aimed at rapid expansion of the upper jaw for young patients[34]. - The acquisition of Cubicure GmbH in January 2024 is expected to enhance the company's 3D printing capabilities, allowing for the direct printing of millions of custom appliances daily[35]. - The iTero Element 5D Imaging System demonstrated 66% greater sensitivity in detecting interproximal lesions compared to traditional bitewing x-rays[43]. - The iTero Lumina intraoral scanner, launched in January 2024, features Multi-Direct Capture technology for improved data capture and scan quality[45]. - The Invisalign Outcome Simulator allows patients to visualize potential treatment results, enhancing patient engagement and acceptance[46]. - The SmartTrack material used in clear aligners maintains more constant force over time, improving control of tooth movements[38]. - The SmartStage Technology optimizes the path of tooth movement, enhancing treatment predictability and outcomes[40]. - The Align Oral Health Suite integrates various diagnostic tools into a single interface, improving the dental consultation experience[46]. Global Expansion and Workforce - The company is expanding its global presence, selling directly or through authorized distributors in over 100 countries by the end of 2024[11]. - As of December 31, 2024, there are approximately 130,370 active Invisalign-trained doctors, defined as those who have submitted at least one Invisalign case in the prior 12-month period[61]. - The company has established 13 fabrication and treatment planning locations worldwide, with manufacturing facilities in Mexico, China, and Poland[11]. - As of December 31, 2024, the company had approximately 20,945 employees, reflecting a decrease of 3.1% from December 31, 2023[79]. - Approximately 91% of the company's employees are located internationally, primarily in direct-labor roles in manufacturing and clinical treatment planning facilities[79]. Research, Development, and Compliance - The company has made significant investments in research and development, focusing on innovations such as SmartTrack aligner materials and AI-powered personalized care[68]. - The company is committed to compliance with various international, federal, and state regulations, including those related to medical devices and data protection[70][75]. - The company is subject to evolving antitrust and competition regulations, which could result in fines and operational changes that materially impact its business[152]. - Compliance with extensive and frequently changing regulations is critical, and failure to do so could result in penalties and harm to the company's reputation[153]. - The company faces significant time, effort, and expense to obtain and maintain regulatory clearances and approvals, with no guarantee of timely success in various markets[155]. - The company is subject to anti-corruption and anti-bribery laws, requiring accurate record-keeping and internal accounting controls to avoid liability[158]. - Compliance with privacy, data protection, and cybersecurity laws is critical, with potential significant penalties for noncompliance, including fines and legal actions[165]. Financial Performance and Market Risks - The company's net revenues are primarily dependent on sales of the Invisalign System and iTero intraoral scanners, with the Invisalign System expected to continue representing the majority of net revenues[115]. - The average selling prices (ASPs) of the Invisalign System and iTero scanners are influenced by factors such as product mix, geographical mix, and foreign currency exchange rates, which could adversely affect net revenues and gross profit[116]. - The company has a history of offering volume discounts and price reductions to stimulate demand, which may lead to reduced net revenues and gross margins[117]. - Competition in the dental industry is increasing, with new technologies and products emerging, potentially rendering existing products obsolete[118]. - The company faces diverse competition, including traditional orthodontic methods and new market entrants offering clear aligners with minimal in-office care[120]. - The company is exposed to fluctuations in foreign currencies, which may adversely impact its financial condition and results of operations[108]. - Macroeconomic conditions, including inflation and consumer confidence, can significantly affect demand for the company's products[105]. - The company faces risks from geopolitical events, tariffs, and trade disputes that could disrupt operations and impact financial performance[109]. Employee Engagement and Corporate Responsibility - The company has received numerous awards for its workplace culture, including recognition as one of the Best Places to Work in various countries[88]. - The company offers a diverse portfolio of approximately 1,800 self-directed courses in up to 80 languages to support employee development[92]. - The company emphasizes pay equity practices and regularly reviews compensation to address discrepancies[95]. - The company has implemented a global initiative called Voyage, which has seen over 45% employee interaction since its launch in 2022[93]. - The company is focused on enhancing the employee experience through regular surveys and feedback mechanisms, resulting in high engagement rates[89]. - The company donated approximately $3.0 million to Operation Smile as of December 31, 2024, supporting free surgeries for individuals with cleft conditions[101]. - The company has provided nearly $2 million to America's ToothFairy, impacting an estimated 2.7 million children since 2019[101]. - During the 2024 fiscal year, the HERO Program positively impacted over 900,000 children and caregivers, reaching more than 600,000 children with educational resources[101]. - The company partnered with INCAE Business School to improve health services in Latin America, providing scholarships to two leaders focused on oral health education[101]. - The company has a commitment to employee health and well-being, sponsoring a Month of Wellness with various activities[96]. - The company maintains dedicated Environmental Health and Safety departments at major worksites to ensure effective health and safety programs[98]. - The company emphasizes the importance of creating safe environments to prevent injuries and occupational diseases[97]. Cybersecurity and Operational Risks - IT systems are critical to the company's operations, and disruptions could materially impact business performance and reputation[134]. - The company faces significant software and hardware risks related to its iTero intraoral scanners, which could materially impact its business and financial results[136]. - A substantial portion of clear aligner production relies on digital scans from the iTero and third-party intraoral scanners, and any failures in interoperability could adversely affect operations and sales[138]. - The company is highly dependent on third-party suppliers for key components, and disruptions in supply could materially affect its financial condition and results of operations[139]. - Changes in key supplier relationships could lead to production interruptions and inefficiencies, potentially resulting in lost revenues[140]. - The company relies on distributors for marketing and sales, and any failure of these distributors to comply with laws could harm the company's reputation and financial results[141]. - Disruptions in freight carrier operations or increased shipping costs could negatively impact the company's supply chain and financial results[142]. - The company is dependent on attracting and retaining skilled personnel, and failure to do so could adversely affect its strategic priorities and financial condition[143]. - The Chief Information Security Officer (CISO) leads the company's information security strategy and has over 20 years of experience in the field[205]. - The company conducts annual cybersecurity enterprise risk assessments and presents the results to management and the Audit Committee[206]. - The Audit Committee oversees the company's cybersecurity risks and meets regularly with the CISO to discuss threats[207].

Company Overview - Healthcare Finance Direct (HFD) is a leading provider of patient financing solutions based in Dallas, Texas, and has partnered with Align Technology, Inc. to offer financing options for Invisalign treatment [1][3] - Align Technology is a global medical device company known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, serving over 271.6 thousand doctor customers and accessing a consumer market opportunity of 600 million worldwide [1][4] Partnership Details - HFD has become a preferred financing partner for Align Technology, allowing US customers to access HFD's patient financing solutions with nearly 100% approval rates for Invisalign treatment applications [1][2] - This partnership aims to alleviate financial constraints for patients seeking orthodontic and dental care, enhancing the support available to Invisalign-trained doctors [2] Financial Impact - HFD has helped over 1 million patients manage more than $2 billion in treatment costs since its inception in 2009, indicating a significant impact on healthcare affordability [3] - The partnership will not only benefit Invisalign treatment but also provide participating doctors with financial programs for other orthodontic and general dentistry services [2]